Tulane has been at the forefront of research on emerging infectious diseases since we were founded to fight the yellow fever outbreak. It is in our DNA to be on the frontlines in the fight against infectious disease and we are uniquely positioned to fight COVID-19 today. Tulane’s Emerging Research in Infectious Disease Fund is providing immediate impact for the COVID-19 crisis, from developing a vaccine, to developing effective testing, to creating new treatments. By supporting Tulane’s promising research and clinical enterprise, your gift will help our scientists make discoveries now that will help us far into the future.